Antibacterial activity and mechanism of a Scorpion venom peptide derivative in vitro and in vivo

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Cao, Luyang ^a   Dai, Chao ^a   Li, Zhongjie ^a   Fan, Zheng ^a   Song, Yu ^a   Wu, Yingliang ^a   Cao, Zhijian ^a   Li, Wenxin ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; KANAMYCIN; KN2 7 PEPTIDE; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; PEPTIDE DERIVATIVE; PLACEBO; SCORPION VENOM; UNCLASSIFIED DRUG; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; BACILLUS THURINGIENSIS; BACTERIAL CELL WALL; BACTERIAL INFECTION; CONTROLLED STUDY; DRUG MECHANISM; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEMOLYSIS; IN VITRO STUDY; IN VIVO STUDY; MESOBUTHUS MARTENSII; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROCOCCUS LUTEUS; MOUSE; NONHUMAN; PSEUDOMONAS AERUGINOSA; SCORPION; SKIN INFECTION; SKIN PROTECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL INFECTIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HEMOLYSIS; MICE; MICROBIAL SENSITIVITY TESTS; SCORPION VENOMS;

BACTERIA (MICROORGANISMS); MESOBUTHUS MARTENSII; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MUS; NEGIBACTERIA; POSIBACTERIA; SCORPIONES; STAPHYLOCOCCUS AUREUS;

EID: 84863624497     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040135     Document Type: Article

References (29)

1. Allen HK, Donato J, Wang HH, Cloud-Hansen KA, Davies J, et al. (2010) Call of the wild: antibiotic resistance genes in natural environments. Nat Rev Microbiol 8: 251-259.
2. Andersson DI, Hughes D, (2010) Antibiotic resistance and its cost: is it possible to reverse resistance? Nat Rev Microbiol 8: 260-271.
3. Hebert C, Weber SG, (2011) Common approaches to the control of multidrug-resistant organisms other than methicillin-resistant Staphylococcus aureus (MRSA). Infect Dis Clin North Am 25: 181-200.
4. Ippolito G, Leone S, Lauria FN, Nicastri E, Wenzel RP, (2010) Methicillin-resistant Staphylococcus aureus: the superbug. Int J Infect Dis 14: S7-11.
5. Brogden NK, Brogden KA, (2011) Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals? Int J Antimicrob Agents 38: 217-225.
6. Maroti G, Kereszt A, Kondorosi E, Mergaert P, (2011) Natural roles of antimicrobial peptides in microbes, plants and animals. Res Microbiol 162: 363-374.
7. Godballe T, Nilsson LL, Petersen PD, Jenssen H, (2011) Antimicrobial beta-peptides and alpha-peptoids. Chem Biol Drug Des 77: 107-116.
8. Zasloff M, (2002) Antimicrobial peptides of multicellular organisms. Nature 415: 389-395.
9. Dai C, Ma Y, Zhao Z, Zhao R, Wang Q, et al. (2008) Mucroporin, the first cationic host defense peptide from the venom of Lychas mucronatus. Antimicrob Agents Chemother 52: 3967-3972.
10. Mygind PH, Fischer RL, Schnorr KM, Hansen MT, Sonksen CP, et al. (2005) Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus. Nature 437: 975-980.
11. Zhao Z, Ma Y, Dai C, Zhao R, Li S, et al. (2009) Imcroporin, a new cationic antimicrobial peptide from the venom of the scorpion Isometrus maculates. Antimicrob Agents Chemother 53: 3472-3477.
12. Fjell CD, Hancock RE, Cherkasov A, (2007) AMPer: a database and an automated discovery tool for antimicrobial peptides. Bioinformatics 23: 1148-1155.
13. Jenssen H, Hamill P, Hancock RE, (2006) Peptide antimicrobial agents. Clin Microbiol Rev 19: 491-511.
14. Fan S, Sun Z, Jiang D, Dai C, Ma Y, et al. (2010) BmKCT toxin inhibits glioma proliferation and tumor metastasis. Cancer Lett 291: 158-166.
15. Ma Y, Zhao R, He Y, Li S, Liu J, et al. (2009) Transcriptome analysis of the venom gland of the scorpion Scorpiops jendeki: implication for the evolution of the scorpion venom arsenal. BMC Genomics 10: 290.
16. Torres-Larios A, Gurrola GB, Zamudio FZ, Possani LD, (2000) Hadrurin, a new antimicrobial peptide from the venom of the scorpion Hadrurus aztecus. Eur J Biochem 267: 5023-5031.
17. Conde R, Zamudio FZ, Rodriguez MH, Possani LD, (2000) Scorpine, an anti-malaria and anti-bacterial agent purified from scorpion venom. FEBS Lett 471: 165-168.
18. Moerman L, Bosteels S, Noppe W, Willems J, Clynen E, et al. (2002) Antibacterial and antifungal properties of alpha-helical, cationic peptides in the venom of scorpions from southern Africa. Eur J Biochem 269: 4799-4810.
19. Dai L, Yasuda A, Naoki H, Corzo G, Andriantsiferana M, et al. (2001) IsCT, a novel cytotoxic linear peptide from scorpion Opisthacanthus madagascariensis. Biochem Biophys Res Commun 286: 820-825.
20. Yuan W, Cao L, Ma Y, Mao P, Wang W, et al. (2010) Cloning and functional characterization of a new antimicrobial peptide gene StCT1 from the venom of the scorpion Scorpiops tibetanus. Peptides 31: 22-26.
21. Zeng XC, Wang SX, Zhu Y, Zhu SY, Li WX, (2004) Identification and functional characterization of novel scorpion venom peptides with no disulfide bridge from Buthus martensii Karsch. Peptides 25: 143-150.
22. Chen Y, Cao L, Zhong M, Zhang Y, Han C, et al. (2012) Anti-HIV-1 Activity of a New Scorpion Venom Peptide Derivative Kn2-7. PLoS One 7: e34947.
23. Fjell CD, Hiss JA, Hancock RE, Schneider G, (2012) Designing antimicrobial peptides: form follows function. Nat Rev Drug Discov 11: 37-51.
24. Melo MN, Ferre R, Castanho MA, (2009) Antimicrobial peptides: linking partition, activity and high membrane-bound concentrations. Nat Rev Microbiol 7: 245-250.
25. Paulmann M, Arnold T, Linke D, Ozdirekcan S, Kopp A, et al. (2012) Structure-activity analysis of the dermcidin-derived peptide DCD 1L, an anionic antimicrobial peptide present in human sweat. J Biol Chem.
26. Mochon AB, Liu H, (2008) The antimicrobial peptide histatin-5 causes a spatially restricted disruption on the Candida albicans surface, allowing rapid entry of the peptide into the cytoplasm. PLoS Pathog 4: e1000190.
27. Brogden KA, (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3: 238-250.
28. Kirillov LV, (1976) [Method of quantitative determination of vaccine activity against botulism of the mink]. Dev Biol Stand 32: 203-209.
29. Hou Z, Lu J, Fang C, Zhou Y, Bai H, et al. (2011) Underlying mechanism of in vivo and in vitro activity of C-terminal-amidated thanatin against clinical isolates of extended-spectrum beta-lactamase-producing Escherichia coli. J Infect Dis 203: 273-282.